Hypofractionated LocoRegional Radiotherapy in Breast Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

588

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2030

Conditions
Breast NeoplasmsRadiotherapyLymphedema
Interventions
RADIATION

Locoregional radiation treatment - Conventional fractionation

40 Gray in 15 daily fractions over 3 weeks

RADIATION

Locoregional radiation treatment - Hypofractionation

26 Gray in 5 daily fractions over 1 week

Trial Locations (20)

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V1Y 5L3

BC Cancer - Centre for the Southern Interior, Kelowna

Unknown

BC Cancer - Centre for the North, Prince George

CHUM - Centre Hospitalier de L'Universite de Montreal, Montreal

CHU-de Québec-Université de Laval, Québec

V5Z 4E6

BC Cancer - Vancouver Centre, Vancouver

V8R 6V5

BC Cancer - Vancouver Island Centre, Victoria

P3E5J1

Northeast Cancer Centre, Health Sciences North, Greater Sudbury

L8V 5C2

Juravinski Cancer Centre, Hamilton

N6A 5W9

London Regional Cancer Program, London

K1H 8L6

The Ottawa Hospital Regional Cancer Centre, Ottawa

M4N 3M5

Sunnybrook Health Sciences Centre - Odette Cancer Centre, Toronto

M5G 1E0

Princess Margaret Cancer Centre - UHN, Toronto

G6V 3Z1

Hotel-Dieu de Lévis (CISSS CA), Lévis

H1T 2M4

CIUSSS de l'Est-de-l'Île de Montréal, Hôpital, Maisonneuve-Rosemont, Montreal

H4A 3J1

McGill University Health Centre-Cedars Cancer Centre, Montreal

J1G 2E8

Sherbrooke University Hospital Centre, Sherbrooke

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

All Listed Sponsors
lead

Ontario Clinical Oncology Group (OCOG)

OTHER